Cocrystal Pharma, Inc. (COCP) Reaches $3.82 52 Week Low; Acxiom (ACXM) Had 6 Bulls

April 17, 2018 - By Linda Rogers

Cocrystal Pharma, Inc. (NASDAQ:COCP) Logo

Among 7 analysts covering Acxiom Corporation (NASDAQ:ACXM), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Acxiom Corporation had 24 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, September 11 by BMO Capital Markets. Stephens maintained Acxiom Corporation (NASDAQ:ACXM) on Friday, February 16 with “Buy” rating. As per Monday, October 16, the company rating was maintained by BMO Capital Markets. As per Wednesday, February 7, the company rating was maintained by Stephens. The firm has “Buy” rating given on Wednesday, June 14 by Cantor Fitzgerald. BMO Capital Markets maintained Acxiom Corporation (NASDAQ:ACXM) rating on Thursday, March 15. BMO Capital Markets has “Outperform” rating and $39 target. The stock of Acxiom Corporation (NASDAQ:ACXM) has “Buy” rating given on Friday, September 22 by Cantor Fitzgerald. The firm has “Buy” rating by Wells Fargo given on Monday, April 2. First Analysis downgraded it to “Equal-Weight” rating and $30 target in Friday, November 18 report. Dougherty & Company initiated Acxiom Corporation (NASDAQ:ACXM) rating on Tuesday, May 24. Dougherty & Company has “Buy” rating and $28 target. See Acxiom Corporation (NASDAQ:ACXM) latest ratings:

16/04/2018 Broker: BMO Capital Markets Rating: Buy New Target: $33.0000 Maintain
02/04/2018 Broker: Wells Fargo Rating: Buy New Target: $33.0000 Maintain
15/03/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $36 New Target: $39 Maintain
08/03/2018 Broker: William Blair Rating: Buy Maintain
16/02/2018 Broker: Stephens Rating: Buy New Target: $35.0 Maintain
07/02/2018 Broker: Stephens Rating: Buy New Target: $31.0 Maintain
07/02/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $32 New Target: $36 Maintain
24/01/2018 Broker: Stephens Rating: Buy New Target: $33.0 Maintain
22/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $32.0 Maintain
31/10/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $33.0 Maintain

The stock of Cocrystal Pharma, Inc. (NASDAQ:COCP) hit a new 52-week low and has $3.71 target or 3.00% below today’s $3.82 share price. The 5 months bearish chart indicates high risk for the $93.22M company. The 1-year low was reported on Apr, 17 by Barchart.com. If the $3.71 price target is reached, the company will be worth $2.80M less. The stock decreased 9.26% or $0.39 during the last trading session, reaching $3.82. About 31,567 shares traded or 189.15% up from the average. Cocrystal Pharma, Inc. (NASDAQ:COCP) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock increased 2.72% or $0.67 during the last trading session, reaching $25.26. About 423,225 shares traded. Acxiom Corporation (NASDAQ:ACXM) has risen 11.14% since April 17, 2017 and is uptrending. It has underperformed by 0.41% the S&P500.

Investors sentiment decreased to 1.13 in Q4 2017. Its down 0.42, from 1.55 in 2017Q3. It dived, as 18 investors sold Acxiom Corporation shares while 62 reduced holdings. 31 funds opened positions while 59 raised stakes. 70.43 million shares or 3.16% less from 72.72 million shares in 2017Q3 were reported. 4.49 million are held by Rgm Ltd Co. 57,016 were accumulated by Arizona State Retirement Sys. 28,495 were accumulated by Gsa Prns Llp. Lord Abbett And Ltd Liability has 0.2% invested in Acxiom Corporation (NASDAQ:ACXM) for 2.55 million shares. Mutual Of America Mngmt Ltd Liability holds 62,930 shares or 0.03% of its portfolio. Sei Investments holds 238,247 shares or 0.02% of its portfolio. Schwab Charles Investment Mgmt, a California-based fund reported 529,882 shares. Moreover, Hsbc Pcl has 0% invested in Acxiom Corporation (NASDAQ:ACXM). Ubs Asset Americas has invested 0% in Acxiom Corporation (NASDAQ:ACXM). Bnp Paribas Arbitrage accumulated 35,805 shares. Schroder Invest Group owns 556,340 shares for 0.03% of their portfolio. New York State Teachers Retirement Sys invested in 0.01% or 151,790 shares. Scout Invests Inc accumulated 0.03% or 47,775 shares. Horrell Cap Management accumulated 0.41% or 28,641 shares. Kbc Group Nv, Belgium-based fund reported 1,935 shares.

Since March 29, 2018, it had 1 buy, and 0 selling transactions for $2,308 activity. BATTELLE JOHN L. bought 100 shares worth $2,308.

Acxiom Corporation operates as a technology and enablement services firm in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $1.99 billion. The firm operates through three divisions: Connectivity, Audience Solutions, and Marketing Services. It has a 205.37 P/E ratio. The Connectivity segment provides a foundational identity resolution layer, which enables its clients to identify and reach clients across channels and measure the impact of marketing on sales.

Cocrystal Pharma, Inc. focuses on developing novel medicines for use in the treatment of human viral diseases. The company has market cap of $93.22 million. It has developed proprietary structure drug design and antiviral nucleoside chemistry to create antiviral drug candidates. It currently has negative earnings. The firm is developing antiviral drug candidates designed to transform the treatment and/or prophylaxis of hepatitis C virus, influenza virus, and norovirus.

Acxiom Corporation (NASDAQ:ACXM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.